FDA Orange Book
Is there a generic for Jideytro?
Jideytro contains zidesamtinib. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Jideytro (zidesamtinib). The Orange Book shows its last listed patent expires September 30, 2042 and its last listed exclusivity ends July 22, 2031.
Run it in Rivvi
Map Jideytro and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Jideytro products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 100MG | Marketed (Rx) | None | 0 | None |
| tablet, oral | 25MG | Marketed (Rx) | None | 0 | None |
NDA 220185, held by NUVALENT INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Jideytro patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 12054498 | May 5, 2041 | Method of use | U-4579 | 220185 |
| 11542278 | May 5, 2041 | Drug substance, Drug product | None | 220185 |
| 12630560 | September 30, 2042 | Method of use | U-4579 | 220185 |
| 12043626 | September 30, 2042 | Drug substance, Drug product | None | 220185 |
Jideytro exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NCE | New chemical entity | July 22, 2031 | 220185 |
Jideytro NDC codes
Questions
Is there a generic for Jideytro?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Jideytro (zidesamtinib). The Orange Book shows its last listed patent expires September 30, 2042 and its last listed exclusivity ends July 22, 2031.
What is the generic name for Jideytro?
The active ingredient in Jideytro is zidesamtinib, per the FDA Orange Book.
When does the Jideytro patent expire?
The last patent listed for Jideytro in the Orange Book expires September 30, 2042. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.